1. A Double‐blind, randomized, placebo‐controlled study to assess the safety, antiviral activity and pharmacokinetics of GSK2336805 when given as monotherapy and in combination with peginterferon alfa‐2a and ribavirin in hepatitis C virus genotype 1‐infected treatment‐naive subjects. (16th October 2013) Authors: Gardner, Stephen; Cutrell, Amy; Elko‐Simms, Cindy; Adkison, Kimberly; Hamatake, Robert; Walker, Jill; Rodriguez‐Torres, Maribel; Hong, Zhi Journal: Liver international Issue: Volume 34:Number 6(2014:Aug.) Page Start: e89 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗